Sequoia
Syner-G BioPharma Group, formerly known as Sequoia Biotech Consulting, is a leading life sciences consultancy dedicated to supporting life science companies in their mission to advance human health. They provide expertise in therapeutics, diagnostics, and medical devices, emphasizing a collaborative, people-first approach to deliver high-quality therapeutics, diagnostics, and medical devices efficiently. With over a decade of experience, they focus on operational excellence, scalable solutions, and fostering innovation across the entire development lifecycle.
Industries
Nr. of Employees
medium (51-250)
Sequoia
West Coast Offices | 315 S. Coast Hwy. 101, Suite U58 Encinitas, CA 92024
Patents
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-11110169-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10525128-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10137192-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10058608-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-9878037-B2
View Details
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-11110169-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10525128-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10137192-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-10058608-B2
View DetailsCompositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US-9878037-B2
View DetailsServices
Advisory and implementation services for QMS, audits, data integrity and regulatory compliance programs.
Execution of CQV programs and method validation for facilities, equipment and analytical methods.
Support for CMC development, process scale-up and technology transfer between development and manufacturing environments.
Facilities engineering, equipment maintenance, CMMS implementation, and 24/7 operational support for labs and GMP facilities.
Program and project management services for facility builds, expansions and technical programs.
Processes and frameworks for selecting and qualifying contract development and manufacturing partners.
Advisory and implementation services for QMS, audits, data integrity and regulatory compliance programs.
Execution of CQV programs and method validation for facilities, equipment and analytical methods.
Support for CMC development, process scale-up and technology transfer between development and manufacturing environments.
Facilities engineering, equipment maintenance, CMMS implementation, and 24/7 operational support for labs and GMP facilities.
Program and project management services for facility builds, expansions and technical programs.
Processes and frameworks for selecting and qualifying contract development and manufacturing partners.
Expertise Areas
- Quality systems and regulatory compliance
- GMP manufacturing operations and scale-up
- Facilities engineering and CMMS
- Commissioning, qualification and validation (CQV)
Key Technologies
- GMP manufacturing processes
- Commissioning and qualification protocols (CQV)
- CMC process workflows
- Process automation and control systems
News & Updates
Sequoia Biotech Consulting has officially rebranded to Syner-G BioPharma Group, reflecting an expanded identity and commitment to end-to-end biopharma development solutions.
The companies announced the appointment of Scott Bergeron as Chief Commercial Officer to drive strategic growth and client success.
The appointment of industry veteran Chris Erickson as Chief Operating Officer to enhance operational excellence.
Sequoia Biotech Consulting has officially rebranded to Syner-G BioPharma Group, reflecting an expanded identity and commitment to end-to-end biopharma development solutions.
The companies announced the appointment of Scott Bergeron as Chief Commercial Officer to drive strategic growth and client success.
The appointment of industry veteran Chris Erickson as Chief Operating Officer to enhance operational excellence.